Most Clicked StoriesMore >


Takeda Pharmaceutical, ImmunoGen sign licensing agreement

BIO SmartBrief | Mar 24, 2015

Takeda Pharmaceutical gained exclusive rights to use ImmunoGen's technology in the development and commercialization of cancer treatments. Takeda will pay ImmunoGen an upfront fee of $20 million and milestone fees of up to $210 million per cancer target, plus royalties. Takeda will oversee the development, production and commercialization of products arising from the deal. Wall Street Journal (tiered subscription model), The (03/23)


Sun Pharmaceutical wraps up merger with Ranbaxy

BIO SmartBrief | Mar 26, 2015

Drug firms, NHS, academia team up for genome project

BIO SmartBrief | Mar 27, 2015

Biotech apples, potatoes receive FDA approval

BIO SmartBrief | Mar 23, 2015

European Commission OKs Novo Nordisk's liraglutide injection for obesity

BIO SmartBrief | Mar 25, 2015

Eli Lilly, Innovent Biologics sign 10-year cancer drug deal

BIO SmartBrief | Mar 23, 2015

HHS funds late-stage trial of Emergent's improved anthrax vaccine

BIO SmartBrief | Mar 25, 2015

Treeway receives orphan drug designation for ALS treatment

BIO SmartBrief | Mar 25, 2015

Analysis: Global market for type 1 diabetes treatment to grow to $13.6B by 2023

BIO SmartBrief | Mar 23, 2015

Public offering brings in $149.5M for Retrophin

BIO SmartBrief | Mar 25, 2015


Find BIO SmartBrief Issues by Date:



BIO News More >


New BIO Survey Tool: FDA/Sponsor Interactions During Drug Development

BIO SmartBrief | Mar 27, 2015

Faster & better connections with quality R&D vendors

BIO SmartBrief | Mar 26, 2015

Industrial biotechnology with a French twist!

BIO SmartBrief | Mar 25, 2015

Savings on environmental waste disposal services

BIO SmartBrief | Mar 24, 2015

Secure document sharing services optimized for life science organizations

BIO SmartBrief | Mar 23, 2015




Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more